↓ Skip to main content

Impact of Collaborative Care for Underserved Patients with PTSD in Primary Care: a Randomized Controlled Trial

Overview of attention for article published in Journal of General Internal Medicine, February 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy
2 policy sources
twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
247 Mendeley
Title
Impact of Collaborative Care for Underserved Patients with PTSD in Primary Care: a Randomized Controlled Trial
Published in
Journal of General Internal Medicine, February 2016
DOI 10.1007/s11606-016-3588-3
Pubmed ID
Authors

Lisa S. Meredith, David P. Eisenman, Bing Han, Bonnie L. Green, Stacey Kaltman, Eunice C. Wong, Melony Sorbero, Christine Vaughan, Andrea Cassells, Douglas Zatzick, Claudia Diaz, Scot Hickey, Jeremy R. Kurz, Jonathan N. Tobin

Abstract

The effectiveness of collaborative care of mental health problems is clear for depression and growing but mixed for anxiety disorders, including posttraumatic stress disorder (PTSD). We know little about whether collaborative care can be effective in settings that serve low-income patients such as Federally Qualified Health Centers (FQHCs). We compared the effectiveness of minimally enhanced usual care (MEU) versus collaborative care for PTSD with a care manager (PCM). This was a multi-site patient randomized controlled trial of PTSD care improvement over 1 year. We recruited and enrolled 404 patients in six FQHCs from June 2010 to October 2012. Patients were eligible if they had a primary care appointment, no obvious physical or cognitive obstacles to participation, were age 18-65 years, planned to continue care at the study location for 1 year, and met criteria for a past month diagnosis of PTSD. The main outcomes were PTSD diagnosis and symptom severity (range, 0-136) based on the Clinician-Administered PTSD Scale (CAPS). Secondary outcomes were medication and counseling for mental health problems, and health-related quality of life assessed at baseline, 6 months, and 12 months. Patients in both conditions improved similarly over the 1-year evaluation period. At 12 months, PTSD diagnoses had an absolute decrease of 56.7 % for PCM patients and 60.6 % for MEU patients. PTSD symptoms decreased by 26.8 and 24.2 points, respectively. MEU and PCM patients also did not differ in process of care outcomes or health-related quality of life. Patients who actually engaged in care management had mental health care visits that were 14 % higher (p < 0.01) and mental health medication prescription rates that were 15.2 % higher (p < 0.01) than patients with no engagement. A minimally enhanced usual care intervention was similarly effective as collaborative care for patients in FQHCs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 247 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 247 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 15%
Researcher 33 13%
Student > Bachelor 26 11%
Student > Ph. D. Student 21 9%
Student > Doctoral Student 19 8%
Other 35 14%
Unknown 75 30%
Readers by discipline Count As %
Medicine and Dentistry 43 17%
Psychology 39 16%
Nursing and Health Professions 28 11%
Social Sciences 21 9%
Agricultural and Biological Sciences 4 2%
Other 22 9%
Unknown 90 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2020.
All research outputs
#3,827,164
of 23,911,072 outputs
Outputs from Journal of General Internal Medicine
#2,601
of 7,806 outputs
Outputs of similar age
#65,911
of 403,931 outputs
Outputs of similar age from Journal of General Internal Medicine
#33
of 102 outputs
Altmetric has tracked 23,911,072 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,806 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 403,931 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.